CinDome Pharma Announces $40 Million Series B Extension
CinDome Pharma Announces $40 Million Series B Extension
CinRx’s CinDome Pharma to Present a Poster on Deudomperidone (CIN-102) at 2023 Digestive Disease Week® Conference
CinRx’s CinDome Pharma to Present a Poster on Deudomperidone (CIN-102) at 2023 Digestive Disease Week® Conference.
CinDome Pharma announces successful completion of thorough QT study of CIN- 102
CinDome Pharma announced the negative results of a clinical thorough QT/QTc study of CIN-102.